Be a Smart Investor
Wednesday, June 13, 2018
SAGE Therapeutics Inc. (SAGE) Surged After FDA Discussion
SAGE Therapeutics Inc. (SAGE) announced an expedited development plan for SAGE-217 Tuesday morning, after a Breakthrough Therapy meeting with the FDA.
from RTT - Before the Bell https://ift.tt/2JIEWtB
via
IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
View mobile version
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment